128 related articles for article (PubMed ID: 6521247)
1. [Effect of systemic thrombolytic therapy on necrotic focus formation in myocardial infarct patients].
Golikov AP; Zvereva TV; Polumiskov VIu; Avilova OA
Kardiologiia; 1984 Sep; 24(9):47-50. PubMed ID: 6521247
[TBL] [Abstract][Full Text] [Related]
2. [Rate of development and the size of the necrotic focus in patients with myocardial infarct treated by intracoronary thrombolysis].
Golikov AP; Zingerman LS; Polumiskov VIu; Berestov AA; Avilova OA
Kardiologiia; 1986 May; 26(5):12-7. PubMed ID: 3735912
[TBL] [Abstract][Full Text] [Related]
3. [Dynamics of a necrotic focus development based on data from determining the activity of the MB CPK fraction and from precardiac mapping].
Vinogradov AV; Chekareva GA; Arutiunov GP; Serov RA; Zhuravleva IA
Kardiologiia; 1981 Sep; 21(9):14-7. PubMed ID: 7311289
[TBL] [Abstract][Full Text] [Related]
4. Early detection of coronary artery patency after thrombolysis by determination of the MM creatine kinase isoforms in patients with acute myocardial infarction. PRIMI Study Group.
Schofer J; Ress-Grigolo G; Voigt KD; Mathey DG
Am Heart J; 1992 Apr; 123(4 Pt 1):846-53. PubMed ID: 1549991
[TBL] [Abstract][Full Text] [Related]
5. [Enzymatic estimation of infarct size in patients undergoing thrombolytic therapy].
Melandri G; Tartagni F; Branzi A; Berardi C; Bruscoli F; Monetti N; Magnani B
Cardiologia; 1988 Jan; 33(1):61-7. PubMed ID: 3365710
[No Abstract] [Full Text] [Related]
6. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous thrombolytic therapy in acute infarct of the myocardium].
Núñez P; Motta J; Arrocha A; Soto V
Rev Med Panama; 1989 Jan; 14(1):16-25. PubMed ID: 2499016
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy: an overview.
Quaal SJ
J Cardiovasc Nurs; 1986 Nov; 1(1):45-56. PubMed ID: 3639919
[No Abstract] [Full Text] [Related]
9. [Possibilities of electrocardiography in the evaluation of necrotization process in posterior myocardial infarction].
Vinogradov AV; Aloev RS; Zhuravleva IA; Kharlap GV; Glazunov AS
Kardiologiia; 1988 Nov; 28(11):58-61. PubMed ID: 3230778
[TBL] [Abstract][Full Text] [Related]
10. Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction.
Schwerdt H; Ozbek C; Fröhlig G; Schieffer H; Bette L
Cardiovasc Res; 1990 Apr; 24(4):328-34. PubMed ID: 2189569
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience using streptodecase in the prehospital stage of treatment of acute myocardial infarct].
Mirrakhimov MM; Baltabaev TB; Tsoĭ NL
Kardiologiia; 1987 Feb; 27(2):21-4. PubMed ID: 3573519
[TBL] [Abstract][Full Text] [Related]
12. What is the role of thrombolytic therapy in acute myocardial infarction?
Ganz W; Geft I
Cardiovasc Clin; 1983; 13(1):163-72. PubMed ID: 6401226
[No Abstract] [Full Text] [Related]
13. Thrombolytic therapy update.
Sipperly ME
Crit Care Nurse; 1985; 5(6):30-4. PubMed ID: 3936680
[No Abstract] [Full Text] [Related]
14. [Intracoronary thrombolytic therapy of acute myocardial infarction].
Astaf'ev VI; Runovich AA; Grigor'ev EG; Kustov VI; Kuril'skaia TE
Grudn Khir; 1985; (5):58-65. PubMed ID: 3905528
[No Abstract] [Full Text] [Related]
15. [Serial determinations of MB CPK activity in the evaluation of the severity of acute myocardial infarct].
Vinogradov AV; Arutiunov GP; Zhuravleva IA; Gel'fand IN; Kharlan GV
Sov Med; 1981; (11):3-6. PubMed ID: 7336240
[No Abstract] [Full Text] [Related]
16. [Clinical significance of the size of the necrotic area and the rate of its formation in the acute period of myocardial infarct].
Vinogradov AV; Arutiunov GP; Gel'fand IN; Glazunov AS; Zhuravleva IA
Kardiologiia; 1984 Sep; 24(9):31-4. PubMed ID: 6521245
[TBL] [Abstract][Full Text] [Related]
17. [The study of the activity of creatine kinase in diagnosis of coronary reperfusion in patients with acute myocardial infarction after thrombolysis].
Mysiak A; Salomon P; Halawa B
Pol Merkur Lekarski; 1999 Aug; 7(38):58-60. PubMed ID: 10522418
[TBL] [Abstract][Full Text] [Related]
18. Comparison of thrombolytic agents: mechanism of action, efficacy, and safety.
Kleven MR
Heart Lung; 1988 Nov; 17(6 Pt 2):750-5. PubMed ID: 3142822
[No Abstract] [Full Text] [Related]
19. [Dynamic characteristics of the electrocardiographic and biochemical indices in myocardial infarct patients undergoing thrombolytic therapy].
Smirnov AA; Dorogun BN; Pomerantsev EV; Khakimov AG; Tagieva IA
Ter Arkh; 1987; 59(10):17-21. PubMed ID: 3433210
[TBL] [Abstract][Full Text] [Related]
20. [Thrombolytic therapy in acute myocardial infarct. 1. Markers for evaluating effectiveness and thrombolytic substances].
Kothe K
Z Gesamte Inn Med; 1990 Apr; 45(7):177-83. PubMed ID: 2198713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
